| 1998 | | Augmented eradication rates of Helicobacter pylori by new combination therapy with lansoprazole, amoxicillin, and rebamipide. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 2003 | | Chemoprevention of Helicobacter pylori-associated gastric carcinogenesis in a mouse model: is it possible? | 김명욱, 김영배, 김진홍, 유병무, 조성원, 한상욱, 함기백 |
| 2003 | | Effect of long-term administration of rebamipide on Helicobacter pylori infection in mice. | 김진홍, 유병무, 이기명, 조성원, 주희재, 함기백 |
| 2017 | | Higher serum interleukin-17A levels as a potential biomarker for predicting early disease progression in patients with hepatitis B virus-associated advanced hepatocellular carcinoma treated with sorafenib | 김보현, 김순선, 김재근, 신성재, 양민재, 유병무, 이광재, 이기명, 이제희, 임선교, 정재연, 조성원, 조효정, 황재철 |
| 2000 | | Loss of TGF-beta signaling contributes to autoimmune pancreatitis. | 함기백 |
| 2012 | | New phytopharmaceutical agent CJ-20001 modulates stress-induced inflammatory infiltration into gastric mucosa | 조성원 |
| 1998 | | Quantitative and qualitative usefulness of rebamipide in eradication regimen of Helicobacter pylori. | 김영수, 김진홍, 이광재, 임현이, 조성원, 주희재, 함기백 |
| 2005 | | Synergism of Helicobacter pylori infection and stress on the augmentation of gastric mucosal damage and its prevention with alpha-tocopherol. | 김영배, 여말희, 조성원, 조용관, 한상욱, 함기백 |
